Stryker Corporation (SYK) is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. Meanwhile, an improvement in price also buoys optimism. Shares of this Zacks Rank #3 (Hold) company have risen 18.4% year to date compared with the industry's 10.5% growth. The S&P 500 Index has increased 18.2% in the same time frame. Stryker, with a market capitalization of $134.6 billion, is one of the world's largest medical device companies operating i ...

Stryker Corporation (SYK) recently announced a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. As a result of the acquisition, Stryker is set to expand its minimally invasive pain management portfolio with differentiated treatments and expand its reach across ambulatory surgery centers. More on the News A significant number of individuals worldwide are impacted by lumb ...

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. Lumbar spinal stenosis affects millions of people globally and is a leading cause of pain and disability. Patients today are seeking minimally invasive treatment options, valuing reduced rec ...

Portage, Michigan, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, at the Encore Boston Harbor. Spencer Stiles, Group President, Orthopaedics and Spine, and Jason Beach, Vice President, Finance and Investor Relations will represent the Company in a session scheduled for 3:00 pm Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Th ...

Stryker Corporation (SYK) has entered into a definitive agreement to acquire care.ai, a privately held company specializing in artificial intelligence (AI)-assisted virtual care workflows, smart room technology and ambient intelligence solutions. This acquisition will bolster Stryker's healthcare IT and wirelessly connected medical device portfolio, reinforcing its commitment to providing cutting-edge solutions that address critical challenges in the healthcare sector, such as nursing shortages and staff re ...

Stryker Corporation (SYK) recently announced the launch of its Pangea Plating System, which received FDA clearance in late 2023. Pangea System is likely to provide variable-angle plating for a range of patient demographics, and its portfolio is both extensive and adaptable. With Pangea System on board, Stryker is now the go-to partner for all things trauma-related, including plates, nails, external fixation devices, and more, supported by the company's committed staff and first-rate service. More on the Pan ...

Stryker Corporation (SYK) recently announced the completion acquisition of MOLLI Surgical Inc., a privately held company specializing in the development of wire-free soft tissue localization technology for breast-conserving surgery. As a result of the acquisition, MOLLI's portfolio is likely to boost Stryker's commitment to advancing surgical solutions in breast cancer care. More on the News The MOLLI 2 localization system is made to be reliable and easy to use to facilitate a surgical workflow that is more ...

andresr/E+ via Getty Images Introduction Stryker (NYSE:SYK) is a manufacturer, developer, and distributor of medical products and devices. The company has global operations around the world and has an impact on over 150 million patients a year. With products like MedSurg, Neurotechnology, Orthopaedics and Spine, the company plays a pivotal role in shaping better patient outcomes. Just recently on July 30, Stryker announced its second quarter results for the year. As I've often been on the lookout for compou ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-13149 STRYKER CORPORATION (Exact name of registrant as specified in its charter) | Michigan | | | 38-1239739 | | --- | --- | --- | --- | | (State of incorporation) | | | (I. ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Stryker (SYK) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-todate performance to find out. The Zacks Consensus Estimate for SYK's full-year earnings has moved 0.1% higher within the past quarter. This signals that analyst sentiment is impr ...